Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AVANIR PHARMACEUTICALS | 74,533 | reported | 04 May 2007 | tx 6+75,100−11,192 |
| FIRST CONSULTING GROUP INC | 6,000 | reported | 31 Jul 2003 | tx 1+3,000 |
| OAKLEY INC | 0 | reported | 14 Nov 2007 | tx 3+9,000−15,386 |
1 purchase reported after at least 12 months of silence — most recent on 25 May 2006.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Nov 2007 | OTHER | OAKLEY INC | 15,386 | 29.30 USD | |
| 01 Jun 2007 | GRANT_AWARD | OAKLEY INC | 4,500 | 0.00 USD | |
| 04 May 2007 | TAX_WITHHOLDING | AVANIR PHARMACEUTICALS | 1,192 | 3.38 USD | |
| 28 Feb 2007 | GRANT_AWARD | AVANIR PHARMACEUTICALS | 10,000 | 0.00 USD | |
| 28 Feb 2007 | EXERCISE | AVANIR PHARMACEUTICALS | 10,000 | 0.00 USD | deriv |
| 13 Dec 2006 | GRANT_AWARD | AVANIR PHARMACEUTICALS | 57,600 | — | |
| 09 Jun 2006 | GRANT_AWARD | OAKLEY INC | 4,500 | 0.00 USD | |
| 25 May 2006 | PURCHASE | AVANIR PHARMACEUTICALS | 2,500 | 9.00 USD | |
| 25 May 2006 | PURCHASE | AVANIR PHARMACEUTICALS | 5,000 | 9.05 USD | first after silence |
| 31 Jul 2003 | PURCHASE | FIRST CONSULTING GROUP INC | 3,000 | 4.70 USD |